Spinocerebellar Ataxia Type 7 Latest Advances
Find the Latest Research About Spinocerebellar Ataxia Type 7
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 213 publications
Nuclear Lamina Dysfunction and DNA Damage as Drivers of Premature Senescence in a Human Müller Glial Cell Model of Spinocerebellar Ataxia Type 7.
Journal: International journal of molecular sciences
Published: May 12, 2026
Loss of astrocytic markers and impaired metabolic function in spinocerebellar ataxia type 7 patient-derived neural cultures.
Journal: Neurobiology of disease
Published: April 24, 2026
Integrated Plasma and Glial Cell Evidence Indicates a Functional Role for hsa-miR-342-5p in Spinocerebellar Ataxia Type 7 and Its Potential Use as a Biomarker.
Journal: International journal of molecular sciences
Published: November 30, 2025
Evaluating Glial Fibrillary Acidic Protein and Neurofilament Light as Potential Biomarkers for Spinocerebellar Ataxia 7.
Journal: International journal of molecular sciences
Published: March 14, 2025
In Silico Analysis of miRNA-Regulated Pathways in Spinocerebellar Ataxia Type 7.
Journal: Current issues in molecular biology
Published: December 31, 2024
Correction: Long-Term Follow-Up Before and During Riluzole Treatment in Six Patients from Two Families with Spinocerebellar Ataxia Type 7.
Journal: Cerebellum (London, England)
Published: September 13, 2024
Current Overview of Spinocerebellar Ataxia Type 7 in Mexican Population: Challenges in Specialized Care for a Rare Disease.
Journal: International journal of molecular sciences
Published: August 31, 2024
Retinal degeneration in spinocerebellar ataxia type 7: an overview of the current knowledge.
Journal: Arquivos brasileiros de oftalmologia
Published: August 22, 2024
Increased nuclear import characterizes aberrant nucleocytoplasmic transport in neurons from patients with spinocerebellar ataxia type 7.
Journal: Frontiers in molecular neuroscience
Published: August 17, 2024
Multi-omic insights into molecular mechanism and therapeutic targets in spinocerebellar ataxia type 7.
Journal: Molecular therapy. Nucleic acids
Published: July 06, 2024
Long-Term Follow-Up before and during Riluzole Treatment in Six Patients from Two Families with Spinocerebellar Ataxia Type 7.
Journal: Cerebellum (London, England)
Published: June 17, 2024
Generation of human induced pluripotent stem cell lines (LUMCi051-A,B and LUMCi052-A,B,C) of two patients with Spinocerebellar ataxia type 7.
Journal: Stem cell research
Published: April 17, 2024
Last Updated: 09/26/2026